Abstract
Gallstones affect 20% of the Western population and will grow in clinical significance as obesity and metabolic diseases become more prevalent. Gallbladder removal (cholecystectomy) is a common treatment for diseases caused by gallstones, with 1.2 million surgeries in the US each year, each costing USD 10,000. Gallbladder disease has a significant impact on the logistics and economics of healthcare. We discuss the two most common presentations of gallbladder disease (biliary colic and cholecystitis) and their pathophysiology, risk factors, signs and symptoms. We discuss the factors that affect clinical care, including diagnosis, treatment outcomes, surgical risk factors, quality of life and cost-efficacy. We highlight the importance of standardised guidelines and objective scoring systems in improving quality, consistency and compatibility across healthcare providers and in improving patient outcomes, collaborative opportunities and the cost-effectiveness of treatment. Guidelines and scoring only exist in select areas of the care pathway. Opportunities exist elsewhere in the care pathway.
Reference130 articles.
1. Open Cholecystectomy. [Updated 27 April 2020];Jones,2020
2. Diagnosis and management of gallstone disease: summary of NICE guidance
3. Gallstones
4. Costing Statement: Gallstone Disease. Implementing the NICE Guideline on Gallstone Disease (CG188)https://www.nice.org.uk/guidance/cg188/resources/costing-statement-pdf-193298365
5. Gallstone Disease: Diagnosis and Gallstone Disease: Diagnosis and Management [Online]http://www.nice.org.uk/guidance/cg188
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献